FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2068079720> ?p ?o ?g. }

• W2068079720 endingPage "1078" @default.
• W2068079720 startingPage "1075" @default.
• W2068079720 abstract "<h3>Background</h3> Hypoxia-inducible factor (HIF)-1α is a critical transcription regulator in cellular response to hypoxic condition. Hypoxic microenvironment exists in rheumatoid arthritis (RA) joints and we have reported that elevated HIF-1α promoted angiogenesis and inflammation in RA. Recent studies showed HIF-1α might promote osteoclast-mediated bone resorption in vitro. However, little was known about its role in RA joint destruction. <h3>Objectives</h3> To explore the correlation of synovial HIF-1α with joint destruction and its progression in RA. <h3>Methods</h3> Patients with active RA were followed up and X-ray assessment of hand/wrist was repeated at baseline and one year. Erosive disease was defined according to 2013 EULAR definition and radiographic progression was defined as the increase of total Sharp score more than 0.5 from baseline to one year. Synovial tissue was obtained from RA patients as well as OA and orthopedic arthropathies (Orth.A) patients. Serial tissue sections were stained with H&E, immunohistochemically for CD3, CD20, CD38, CD68, CD15, CD34 and HIF-1α. Krenn9s synovitis score was semi-quantitatively assessed and the density of positive-staining cells was quantitatively determined. <h3>Results</h3> (1) Twenty five RA patients fulfilled 1 year follow-up, 84% were female, age (median and IQR, similarly hereinafter) was 50 (40–57) years, disease duration was 24 (10–48) months and disease activity SDAI was 35.0 (25.3–46.3). (2) HIF-1α expressed in lining and sublining area with intense nuclear and endochylema staining in RA synovium and the percentage of HIF-1α+ cells [57% (31%–77%)] was significantly higher than that in OA [<i>n</i>=13, 25% (9%–41%), <i>P</i>=0.022]or Orth.A [<i>n</i>=8, 21% (12%–38%), <i>P</i>=0.021, Fig.1]. The percentage of HIF-1α+ cells significantly correlated with subscore of synovial stroma activation, CD34+ microvessel count, CD68+ macrophage count and CD15+ neutrophil count (<i>r</i>=0.420–0.586, all <i>P</i><0.05). (3) Eleven (44%) RA patients had erosive disease at baseline. The percentage of HIF-1α+ cells was significantly higher in erosive patients than non-erosive patients [78% (49%–82%) vs 47% (23%–62%), <i>P</i>=0.014]. ROC curve analysis showed that the tradeoff value of synovial HIF-1α for diagnosing erosive disease was 69% with sensitivity 73% and specificity 100% (<i>AUC</i>=0.792, 95%<i>CI:</i> 0.574–1.010, <i>P</i>=0.014). Patients were then divided into high (n=8) and low synovial HIF-1α (n=17) groups. Total Sharp score and erosion subscore were higher in patients with high synovial HIF-1α than that in patients with low synovial HIF-1α [33 (14–69) vs 10 (4–24), 18 (11–25) vs 3 (2–12), respectively, all <i>P</i><0.05] (4) Eight (32%) RA patients showed radiographic progression at one year. The percentage of HIF-1α+ cells was significantly higher in progressive patients than non-progressive patients [80% (58%–85%) vs 49% (18%–63%), <i>P</i>=0.018]. ROC curve analysis showed that the tradeoff value of synovial HIF-1α for predicting 1-year radiographic progression was 66% with sensitivity 75% and specificity 82% (<i>AUC</i>=0.798, 95%<i>CI</i> :0.576–1.019, <i>P</i>=0.018). Univariate logistic regression showed that high level of synovial HIF-1α was a significant predictor of 1-year radiographic progression (<i>P</i>=0.011, <i>OR</i>=14.00, 95%<i>CI:</i> 1.841 to 106.465). <h3>Conclusions</h3> HIF-1α might play important roles in the pathogenesis of joint destruction in RA. <h3>Acknowledgements</h3> This work was supported by National Natural Science Foundation of China (81471597). <h3>Disclosure of Interest</h3> None declared" @default.
• W2068079720 created "2016-06-24" @default.
• W2068079720 creator A5004143305 @default.
• W2068079720 date "1959-04-25" @default.
• W2068079720 modified "2023-09-25" @default.
• W2068079720 title "Treatment of Heart Failure in Haemochromatosis" @default.
• W2068079720 cites W1491371047 @default.
• W2068079720 cites W1874647655 @default.
• W2068079720 cites W1988321671 @default.
• W2068079720 cites W1988486761 @default.
• W2068079720 cites W1993630306 @default.
• W2068079720 cites W2023981089 @default.
• W2068079720 cites W2051558470 @default.
• W2068079720 cites W2067081170 @default.
• W2068079720 cites W2231592146 @default.
• W2068079720 cites W2395634403 @default.
• W2068079720 cites W2396371396 @default.
• W2068079720 cites W2401134803 @default.
• W2068079720 cites W2409459054 @default.
• W2068079720 cites W2434425668 @default.
• W2068079720 cites W2436151428 @default.
• W2068079720 cites W2462537818 @default.
• W2068079720 cites W2470288602 @default.
• W2068079720 cites W4299582610 @default.
• W2068079720 doi "https://doi.org/10.1136/bmj.1.5129.1075" @default.
• W2068079720 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1993049" @default.
• W2068079720 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/13638634" @default.
• W2068079720 hasPublicationYear "1959" @default.
• W2068079720 type Work @default.
• W2068079720 sameAs 2068079720 @default.
• W2068079720 citedByCount "9" @default.
• W2068079720 countsByYear W20680797202013 @default.
• W2068079720 crossrefType "journal-article" @default.
• W2068079720 hasAuthorship W2068079720A5004143305 @default.
• W2068079720 hasBestOaLocation W20680797202 @default.
• W2068079720 hasConcept C126322002 @default.
• W2068079720 hasConcept C177713679 @default.
• W2068079720 hasConcept C2776590208 @default.
• W2068079720 hasConcept C2778198053 @default.
• W2068079720 hasConcept C41008148 @default.
• W2068079720 hasConcept C71924100 @default.
• W2068079720 hasConceptScore W2068079720C126322002 @default.
• W2068079720 hasConceptScore W2068079720C177713679 @default.
• W2068079720 hasConceptScore W2068079720C2776590208 @default.
• W2068079720 hasConceptScore W2068079720C2778198053 @default.
• W2068079720 hasConceptScore W2068079720C41008148 @default.
• W2068079720 hasConceptScore W2068079720C71924100 @default.
• W2068079720 hasIssue "5129" @default.
• W2068079720 hasLocation W20680797201 @default.
• W2068079720 hasLocation W20680797202 @default.
• W2068079720 hasLocation W20680797203 @default.
• W2068079720 hasLocation W20680797204 @default.
• W2068079720 hasOpenAccess W2068079720 @default.
• W2068079720 hasPrimaryLocation W20680797201 @default.
• W2068079720 hasRelatedWork W1998556240 @default.
• W2068079720 hasRelatedWork W2115795314 @default.
• W2068079720 hasRelatedWork W2141247331 @default.
• W2068079720 hasRelatedWork W2417522246 @default.
• W2068079720 hasRelatedWork W2748952813 @default.
• W2068079720 hasRelatedWork W2763805509 @default.
• W2068079720 hasRelatedWork W2899084033 @default.
• W2068079720 hasRelatedWork W3030465064 @default.
• W2068079720 hasRelatedWork W4247718175 @default.
• W2068079720 hasRelatedWork W4313444034 @default.
• W2068079720 hasVolume "1" @default.
• W2068079720 isParatext "false" @default.
• W2068079720 isRetracted "false" @default.
• W2068079720 magId "2068079720" @default.
• W2068079720 workType "article" @default.